Fifth Third Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Fifth Third Wealth Advisors's BMY Position: Q3 2026 in Review
Fifth Third Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 2.3% in Q3 2026, selling an estimated $94.9K and leaving 63,912 shares worth $3.99M. The position accounts for 0.11% of the portfolio, ranked #144.
Fifth Third Wealth Advisors first reported a position in BMY in Q2 2023 and has held it in 14 quarters since. The position peaked at $4.56M in Q1 2026. 834 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Fifth Third Wealth Advisors held 63,912 shares of Bristol-Myers Squibb worth $3.99M as of Q3 2026.
- Fifth Third Wealth Advisors sold 1,501 Bristol-Myers Squibb shares in Q3 2026, an estimated $94.9K.
- Bristol-Myers Squibb made up 0.11% of Fifth Third Wealth Advisors's portfolio in Q3 2026, its #144 holding.
- Fifth Third Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 14 quarters since.
- Fifth Third Wealth Advisors's Bristol-Myers Squibb position peaked at $4.56M in Q1 2026.
- 834 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Fifth Third Wealth Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.